711results about "Mutant preparation" patented technology

The invention discloses bacillus velezensis Scm3 and application thereof.The bacillus velezensis Scm3 is obtained by screening a strain Scm with an inhibition effect on aeromonas hydrophila from turbot intestinal contents and then conducting ultraviolet mutagenesis on the strain to obtain a strain Scm3 with an enhanced antagonism effect on aeromonas hydrophila, and the strain Scm3 is applied to the preparation of the bacillus velezensis Scm3 and the application of the bacillus velezensis Scm3 to prepare the bacillus velezensis Scm3. 16SrDNA (deoxyribonucleic acid) sequence identification and genome sequencing prove that the strain is bacillus velezensis, and the inhibition mechanism of the bacillus velezensis Scm3 on aeromonas hydrophila is researched by a non-contact co-culture method.

Some aspects of this disclosure provide strategies, systems, reagents, methods, and kits that are useful for the targeted editing of nucleic acids, including editing a single site within the genome of a cell or subject, e.g., within the human genome. In some embodiments, fusion proteins of Cas9 and nucleic acid editing enzymes or enzyme domains, e.g., deaminase domains, are provided. In some embodiments, methods for targeted nucleic acid editing are provided. In some embodiments, reagents and kits for the generation of targeted nucleic acid editing proteins, e.g., fusion proteins of Cas9 and nucleic acid editing enzymes or domains, are provided.

The invention discloses a breeding method of high-concentration cane molasses tolerant robust saccharomyces cerevisiae and high-concentration ethanol fermentation application of the high-concentration cane molasses tolerant robust saccharomyces cerevisiae, and belongs to the technical field of biology. The Saccharomyces cerevisiae NGTM-F1 disclosed by the invention is preserved in the Guangdong Microbial Culture Collection Center on July 25, 2023, and the number of the Saccharomyces cerevisiae NGTM-F1 is GDMCC 63687. The Saccharomyces cerevisiae NGTM-F1 disclosed by the invention is named as Saccharomyces cerevisiae NGTM-F1. The saccharomyces cerevisiae is obtained by taking laboratory saccharomyces cerevisiae GJ08 as an original strain, carrying out ARTP (room temperature plasma) mutagenesis and adaptive evolution breeding and utilizing high-throughput screening, keeps a good growth state in cane molasses with the total sugar being 300 g / L, and has good fermentation performance in cane molasses with the total sugar being 250 g / L at the temperature of 30 DEG C. Under the condition of 30 DEG C in a conical flask, the total sugar consumed by fermentation is 250 g / L, the ethanol concentration can reach 102.30 g / L, and the fermentation efficiency is 80.8%; under the condition of 30 DEG C in a 5 L fermentation tank, the total sugar consumed by fermentation is 250 g / L, the ethanol concentration can reach 111.65 g / L, and the fermentation efficiency is 87.0%.

Some aspects of this disclosure provide strategies, systems, reagents, methods, and kits that are useful for the targeted editing of nucleic acids, including editing a single site within the genome of a cell or subject, e.g., within the human genome. In some embodiments, fusion proteins of Cas9 and nucleic acid editing enzymes or enzyme domains, e.g., deaminase domains, are provided. In some embodiments, methods for targeted nucleic acid editing are provided. In some embodiments, reagents and kits for the generation of targeted nucleic acid editing proteins, e.g., fusion proteins of Cas9 and nucleic acid editing enzymes or domains, are provided.

The invention discloses propionibacterium capable of obtaining high-yield propionic acid through compound mutation screening and a method for fermenting propionic acid by using the propionibacterium. The high-yield propionic acid strain YCBS010 (CGMCC No.31160) is obtained by carrying out compound mutagenesis on acid-producing propionibacterium CGMCC 1.2232 serving as an original strain through microwave-ultrasonic combined mutagenesis and compound normal-pressure and room-temperature plasma (ARTP) mutagenesis means. According to the invention, YPA15 is used as a starting strain, microwave and ultrasonic combined mutagenesis is carried out for 100 seconds to screen a bacterial strain with increased propionic acid yield, then ARTP mutagenesis is carried out for 90 seconds to screen out a high-yield mutant strain YCBS010, fermentation in a 1-ton tank verifies that the highest propionic acid yield reaches 65.87 g / L and the fermentation intensity is 0.73 g / L.h after fermentation is carried out for 90 hours, and the bacterial strain has better industrial fermentation potential.

The invention discloses an EMS-ARTP compound mutation chlorella pyrenoidosa mutant strain and an application thereof. The preparation method comprises the following steps: mutagenizing a chlorella pyrenoidosa mutant strain CX41 by adopting an ethyl methanesulfonate (EMS) and normal-pressure and room-temperature plasma (ARTP) composite technology, screening and verifying to obtain a golden yellow chlorella pyrenoidosa mutant strain, naming the golden yellow chlorella pyrenoidosa mutant strain as chlorella pyrenoidosa Y11, and screening and verifying the golden yellow chlorella pyrenoidosa Y11 to obtain the chlorella pyrenoidosa Y11. The strain is preserved in Guangdong Microbial Culture Collection Center (GDMCC) on the fifth floor of the building 59, No. 100 courtyard, Xianlie Middle Road, Guangzhou on October 23, 2024, and the preservation number is GDMCC No: 65324. The chlorella pyrenoidosa mutant strain Y11 has the characteristics of high yield of protein and rich carotenoids, and can be used for fermentation production of microalgae protein and carotenoids.

The invention belongs to the technical field of microbial mutagenesis, and particularly relates to a microbial mutagenesis breeding device and application thereof. The microorganism mutation breeding device comprises a cube structure and a transmission structure, the periphery of the cube structure is wrapped with a light-proof material, and an ultraviolet lamp is arranged in the cube structure; the transmission structure comprises a single sequencing area and a mutagenesis area, and the mutagenesis area is inserted into the cube structure through the insertion opening of the cube structure and is perpendicular to the ultraviolet lamp. Microorganisms can be singly sorted through the first horizontal spiral conveying pipeline in the single sorting area and conveyed to the second horizontal spiral conveying pipeline in the mutagenesis area, so that the time and the intensity of ultraviolet irradiation of the microorganisms are uniform, the mutagenesis fatality rate of the microorganisms is remarkably reduced, the forward mutation rate is remarkably increased, and the mutagenesis rate of the microorganisms is remarkably increased. Operation is simple, workload is small, and period is short. In addition, the microorganisms are treated by using a protective agent with specific composition before single sequencing, so that the mutation uniformity and the forward mutation rate can be further improved.

Strategies, systems, methods, reagents, and kits for phage-assisted continuous evolution are provided herein. These include strategies, systems, methods, reagents, and kits allowing for stringency modulation to evolve weakly active or inactive biomolecule variants, negative selection of undesired properties, and / or positive selection of desired properties.

The present disclosure relates to enriched engineered glycoprotein populations with a therapeutically optimized heterogeneous glycan profile. The heterogeneous glycan profile comprises sialylated complex type glycans, which are associated with improved efficacy of the glycoprotein. The present disclosure also relates to compositions and uses of the engineered glycoprotein populations and cell-based method of producing them.

Provided herein are binding molecules comprising a human neonatal Fc receptor (FcRn) binding molecule and a moiety that does not specifically bind to a human antigen. Polynucleotides, vectors, host cells, and methods of production are also provided herein. Methods of treating an antibody-mediated disorder with an FcRn binding molecule or an FcRn / antigen-binding molecule are further provided.

The invention relates to the technical field of microorganisms, in particular to streptomyces noursei and application of the streptomyces noursei in preparation of polymycotin B. The invention provides streptomyces noursei GBC A-20 which is preserved in the general microbiological center of the China Committee for Culture Collection of Microorganisms, and the preservation number of the streptomyces noursei GBC A-20 is CGMCC No.27277. The strain can be used for efficiently fermenting and producing the multi-fungal element B by utilizing cheap raw materials, the yield of the multi-fungal element B is remarkably improved, and the chemical titer and the biological titer of the fermentation product nysfungin are greatly improved; the strain and the application thereof provide an economical and feasible solution for the industrial production of the multi-fungal element B and the nysfungin.

The invention belongs to the technical field of microorganism mutation breeding, and particularly relates to a nisin high-yield mutant strain with enhanced production performance. The mutant strain is specifically lactococcus lactis 2686, and the preservation number of the mutant strain is CCTCC (China Center for Type Culture Collection) NO: M 2023219. The strain has relatively high osmotic pressure tolerance, can still normally grow and produce nisin when the osmotic pressure is higher than 0.66 osM / kg H2O, meanwhile, the strain has excellent nisin production capacity, the titer reaches 9834 IU / mL when the strain is fermented in a shake flask for 21 hours, and the titer reaches 21000 IU / mL when the strain is fermented in a fermentation tank for 22 hours. The method is high in yield, good in stability, low in production cost and suitable for further industrial application.

The present invention provides a protein variant, a Corynebacterium genus microorganism comprising the protein variant, and a method for producing L-lysine using the microorganism of the present disclosure.

A microorganism according to the present disclosure is a microorganism (accession number: NITE BP-03832) belonging to Bacillus velezensis, a microorganism (accession number: NITE BP-04073) belonging to Bacillus velezensis, a microorganism (accession number: NITE BP-04126) belonging to Bacillus velezensis, or a variant of these having a plant disease prevention effect.

Telomerase reverse transcriptase (TERT) expression enhancing compounds, and methods for using the same, are provided. These compounds and methods find use in a variety of applications in which increased expression of telomerase reverse transcriptase is desired.

A Schizochytrium algae strain rich in n-3 fatty acid and a screening and culture method therefor. Compared with a conventional strain, the content of EPA and the content of n-3 DPA in the provided strain are greatly improved, and the strain has good genetic stability, fast growth rate and good industrialization prospects. Also provided are a culture medium for mutagenesis of Schizochytrium sp., a culture medium for screening Schizochytrium sp., and a suitable mutagenesis method and screening method.

The invention provides a phaffia rhodozyma mutant strain for high yield of astaxanthin as well as a screening method and application of the phaffia rhodozyma mutant strain, belongs to the technical field of fermentation microorganism screening, and can solve the problems of low astaxanthin yield, high cost and low growth temperature of wild type phaffia rhodozyma existing in synthesis of astaxanthin from a phaffia rhodozyma strain. The invention provides a phaffia rhodozyma mutant strain capable of producing astaxanthin at high yield, the phaffia rhodozyma mutant strain is a phaffia rhodozyma AA0529 mutant strain, the phaffia rhodozyma AA0529 mutant strain is preserved in China Center for Type Culture Collection in Wuhan, Hubei on September 7, 2023, and the preservation number is CCTCC (China Center for Type Culture Collection) NO: M20231637. According to the method, the yield of the astaxanthin can be increased, and the yield of the astaxanthin is increased to 3.3 mg / g at 26 DEG C.

A method and application of Escherichia coli BL21star (DE3) BLBRTXST3 and its fermentation method for producing high-purity lactose-N-neotetraose, the invention relates to the technical field of human milk oligosaccharide production, Escherichia coli )BL21 star (DE3) BLBRTXST3 is deposited in the General Microbiology Center of China Microorganism Culture Collection Committee, with the deposit number CGMCC No. 32521 and the deposit date November 6, 2024. The address of the deposit institution is No. 3, Yard No. 1, Beichen West Road, Chaoyang District, Beijing; Escherichia coli ( Escherichia coli )BL21 star (DE3) BLBRTXST3 is used in the fermentation production of lactose-N-neotetraose (LNnT). The present invention improves the yield of lactose-N-neotetraose, uses a chromatographic simulated moving bed to produce high-purity lactose-N-neotetraose with a purity greater than 94%, replaces the traditional solvent crystallization method, has simple separation and purification, is conducive to industrial production, and simultaneously produces linear lactose-N-neohexaose with a purity greater than 95%.

The present invention provides an improved Bacillus cell having reduced expression of a metalloprotease gene. Inactivation of the metalloprotease gene reduces proteolytic degradation of a protein of interest produced by said Bacillus cell and thus, improves the yield of the protein of interest in such production method. The present invention is also directed to a method of inactivating the metalloprotease and the application of this method of inactivation when producing a protein of interest.

The invention discloses a method for screening high-yield recombinant human lactoferrin through nucleic acid aptamer-assisted mutagenesis of a trichoderma reesei strain and application, and belongs to the technical field of microorganisms. The nucleic acid aptamer Lac-6a-FAM-BHQ1 capable of changing the fluorescence intensity according to the content of lactoferrin is constructed on the basis of the aptamer Lac-6a, and the nucleic acid aptamer can be used for rapidly selecting a mutant strain for producing high-titer recombinant human lactoferrin. The ARTP mutagenesis technology is combined with a nucleic acid aptamer auxiliary screening system, the mutant strain with the improved recombinant human lactoferrin yield is rapidly obtained from a large number of mutant strains, and the yield reaches 274.57 mg / L and is improved by 24.8% compared with that of an original strain. After the genes 111681 and 62716 are over-expressed in T. reesei, compared with a control strain, the yields of the recombinant human lactoferrin of the recombinant strain are respectively increased by 6.9% and 22.1%.

In traditional plant breeding approaches, chemical mutagenesis may be utilized to introduce nucleotide substitutions at random in the genome of a plant, i.e. without possibilities to control the sites of nucleotide changes. Because of genome complexities, the statistical probability is extremely little when it comes to finding a predetermined nucleotide substitution. The present invention, however, demonstrates how a novel, alternative use of digital polymerase chain reaction (dPCR), preferably droplet dPCR (ddPCR), is developed to exploit finding of specific nucleotide substitutions in mutated genes. The entire platform comprises a screening method with a library of mutagenized organisms, digital PCR-based systems and a set-up to propagate and analyze identified, mutated organisms.

The invention relates to the technical field of industrial biology, in particular to streptomyces albus SY6 and a fermentation seed and application thereof, the streptomyces albus SY6 is characterized in that the streptomyces albus SY6 is preserved in China General Microbiological Culture Collection Center on November 13, 2024, the preservation number is CGMCC No.32602, and the streptomyces albus is classified and named as streptomyces albus. The streptomyces albidus SY6 screened by the invention has a better promotion effect in the aspects of mediating a mould signal and strengthening epsilon-polylysine synthesis.

The invention provides a morchella sextelata strain pleurospermum hookeri No.5 and application thereof, and relates to the technical field of strain breeding, the morchella sextelata strain pleurospermum hookeri No.5 is subjected to aerospace carrying to induce genetic variation, then characters capable of being stably inherited are screened out through subculture, and the morchella sextelata strain pleurospermum hookeri No.5 is obtained through fruiting screening test screening. The pleurospermum hookeri

The invention provides a recombinant parasite, which is a member of the phylum Apicomplexa or Euglenozoa, and which comprises a genome which lacks a native gene encoding Toxoplasma gondii IFT88, SRS15A, SRS15B, and / or SRS15C, SRS26B, a native homolog or ortholog thereof, or a combination of two or more of these. The invention also provides a method for producing the recombinant parasite, which involves knocking out one or more of these genes from the genome of the parasite. Reagents for accomplishing this are provided, as are vaccine compositions comprising the inventive recombinant parasites and vaccine compositions comprising a Toxoplasma gondii IFT88, SRS15A, SRS15B, and / or SRS15C, SRS26B protein or homolog or ortholog thereof, or a combination of two or more thereof. Methods of vaccinating animals using such vaccine compositions also are provided.

Certain one or more embodiments of the instant disclosure are related to, inter alia, recombinant (genetically modified) filamentous fungal cells (strains) producing proteins of interest, methods and compositions for the design and construction of modified filamentous fungal cells producing proteins of interest, methods and compositions for the expression / production / secretion / recovery and the like of endogenous and / or heterologous proteins of interest (e.g., phytases, lipases, glucoamylases, phospholipases, esterases, cellulases, hemicellulases, xylanases, etc.) in modified filamentous fungal cells, methods and compositions for producing proteins of interest in recombinant filamentous fungal, wherein the proteins produced and secreted into the broth and / or proteins recovered from the broth have uniform and consistent N-linked glycosylation patterns, and / or reduced (unwanted) glycation of one or more proteins of interest, and the like.

The invention provides a schizochytrium limacinum mutant strain for producing eicosapentaenoic acid as well as a mutagenesis method and application of the schizochytrium limacinum mutant strain, and belongs to the technical field of microorganisms. In order to culture a new EPA high-yield microbial strain, the method comprises the following steps: firstly, carrying out high-throughput screening based on Nile red staining on schizochytrium limacinum by utilizing a method of combining normal-pressure and room-temperature plasma (ARTP) mutagenesis and sethoxydim pressure, so as to obtain a high-fat-content mutant strain; then the high-fat-content mutant strain is used for diethyl sulfate (DES) mutation breeding, a triclos-2, 2-bipyridine composite plate screening technology, shake flask fermentation and GC quantitative analysis to breed an EPA high-yield strain, and finally the schizochytrium limacinum high-yield mutant strain DBT-64 is obtained. The mutant strain DBT-64 is subjected to passage for many times, the character is stable, the yield of EPA is increased by 490.33%, the economic effect is remarkable, and the mutant strain DBT-64 can be used for commercial production of EPA.

This disclosure provides a number of sequences involved in axillary bud growth in tobacco, methods of using such sequences, tobacco plants carrying modifications to such sequences or transgenes of such sequences, and tobacco products made from tobacco leaf harvested from such plants.

Disclosed are modified strains of Chlorella vulgaris having a very low chlorophyll content. Also disclosed is a method for producing them. The method involves performing mutagenesis of a parental strain of Chlorella vulgaris. Furthermore, disclosed is a composition comprising algae biomass derived from the modified strains of Chlorella vulgaris and their use in food and / or cosmetics amongst other applications.

The present disclosure pertains to a Methanothermobacter wolfeii archaeal strain identified as BSEL1 and progeny and mutants thereof. The archaeal strain BSEL1 is capable of growing and producing renewable natural gas (RNG) from a supply of carbon dioxide (CO2) and hydrogen (H2) without the addition of organic supplements, and further to grow in wastewater with an exceptionally high growth rate. The strain is further capable of reducing CO2 to a very low level when grown, e.g., in a trickling bed reactor. BSEL1 is of major importance for direct addition of RNG into the natural gas grid.

Provided is a method for promoting sexual maturity in fish, comprising a step for inhibiting functional expression of at least one of a leptin receptor and leptin in fish. The present invention addresses the problem of providing a method for promoting sexual maturity of a fish in order to obtain an individual fish capable of ovulating or spermising at an age of 1 more than under natural or conventional culture conditions.